Animal Health Market Report Scope & Overview:
The Animal Health Market was valued at USD 67.13 billion in 2025 and is expected to reach USD 187.03 billion by 2035, growing at a CAGR of 10.79% from 2026-2035.
The animal health market is being driven by an increase in pet ownership, more investments in veterinary medicine, and awareness concerning animal disease prevention. With the increasing demand for high-grade meat products, dairy, and poultry, livestock owners are investing more in animal health by purchasing vaccines, diagnostic equipment, and feed additives. New technology developments in veterinary medicine, pharmaceuticals, and precision livestock farming technologies are driving the expansion of the market. Furthermore, an increased focus on preventive healthcare services, pet insurance, and stricter regulatory requirements for food safety and zoonoses control is boosting the growth of the global animal health market.
According to the American Pet Products Association (APPA), U.S. pet industry spending exceeded $150 billion in 2025, supported by increasing expenditure on veterinary care, diagnostics, medicines, and preventive healthcare services. Furthermore, the Food and Agriculture Organization (FAO) states that global meat production continues to rise to meet growing protein consumption, encouraging livestock producers to adopt vaccines, feed additives, and disease management programs to improve productivity, animal welfare, and disease control.
Market Size and Forecast
-
Market Size 2026E: USD 74.37 Billion
-
Market Size 2035: USD 187.03 Billion
-
CAGR (2026-2035): 10.79%
-
Fastest Growing Market: Asia Pacific
-
Largest Market: North America

To Get more information On Animal Health Market - Request Free Sample Report
Animal Health Market Trends
-
Rising pet ownership and increasing focus on livestock health management are driving the animal health market.
-
Growing adoption of vaccines, pharmaceuticals, diagnostics, and feed additives is boosting market growth.
-
Expansion of veterinary healthcare infrastructure and preventive care practices is fueling market demand.
-
Increasing focus on zoonotic disease prevention, animal nutrition, and productivity improvement is shaping adoption trends.
-
Advancements in biologics, precision livestock farming, and digital veterinary solutions are enhancing treatment effectiveness and monitoring capabilities.
U.S. Animal Health Market Size Outlook
The U.S. Animal Health Market was valued at USD 23.31 billion in 2025 and is expected to reach USD 63.67 billion by 2035, growing at a CAGR of 10.57% from 2026-2035.
The U.S. animal health market is witnessing growth owing to high pet ownership, growing expenditure in veterinary care services, and growing awareness about preventive animal health care. The increased demand for disease management in livestock, sophisticated diagnostic tools, vaccines, and nutrition is boosting the market. The development of technology in the field of veterinary care solutions is aiding the growth.

Animal Health Market Segment Analysis
-
By Animal Type, production animals segment dominated the Animal Health Market in 2025 with 58.30% share; companion animals segment is the fastest-growing (CAGR).
-
By Product, pharmaceuticals segment dominated the Animal Health Market in 2025 with 41.70% share; diagnostics segment is the fastest-growing (CAGR).
-
By Distribution Channel, retail segment dominated the Animal Health Market in 2025 with 46.20% share; e-commerce segment is the fastest-growing (CAGR).
-
By End Use, veterinary hospitals & clinics segment dominated the Animal Health Market in 2025 with 44.80% share; point-of-care testing segment is the fastest-growing (CAGR).
By Animal Type, production animals segment dominated the animal health market in 2025, companion animals segment is the fastest growing
Production animals segment dominated the animal health market in 2025 due to an increasing demand for meat, dairy, and poultry products globally. Livestock producers and farmers spend significantly on animal healthcare products that enhance productivity and provide protection against diseases. Increased consciousness related to food safety, management of zoonotic diseases, and improved performance of livestock contributes towards high demand. Both governments and agricultural firms are now emphasizing the importance of preventive healthcare and immunization programs which have made the production animals segment become the highest revenue generating segment in the global animal health market.
Companion animals segment is the fastest growing segment within the animal health market due to high rate of pet ownership, increased pet-human interaction, and higher spending on their health by pet owners. Consumers are giving more emphasis on preventive healthcare, advanced healthcare services and regular diagnostic tests to promote the wellbeing of animals. Growing awareness towards pet nutrition, management of chronic diseases in pets and insurance coverage for them are some other factors driving rapid adoption of companion animals' healthcare products.

By Product, pharmaceuticals segment dominated the animal health market in 2025, diagnostics segment is the fastest growing
The pharmaceuticals segment led the animal health market in 2025 owing to increased usage of vaccines, anti-infective drugs, parasiticides, and analgesics among other medicines that treat or manage various diseases in domestic and wild animals. The continued rise in incidences of animal diseases coupled with the emphasis on preventive care remains the major catalysts fueling demand for animal health products. Veterinary professionals depend on pharmaceutical drugs for the treatment and enhancement of productivity among animals. Increased R&D investments for developing animal drugs along with growing concern for the wellbeing of animals reinforce the dominance of pharmaceuticals in the animal health industry.
The diagnostics segment emerged as the fastest-growing segment in the animal health market owing to an increased interest in the detection of animal diseases at the earliest possible time, preventive care, and timely treatment plans. Advancements in technologies that aid veterinary clinics and livestock farmers to effectively screen animal diseases remain one of the key growth drivers for this segment. In addition, increased prevalence of infectious diseases and growing awareness about the importance of health screening among animals also boost adoption rates in this segment.
By Distribution Channel, retail segment dominated the animal health market in 2025, e-commerce segment is the fastest growing
The retail segment was leading the market in 2025 because of good availability of drugs, medicines, supplements, and care products from pharmacies, pet stores, and veterinary outlets. Consumers have preference for retail outlets because they are convenient and easily accessible with readily available professional assistance for any queries related to animal health. Higher pet ownership along with higher expenditure on livestock healthcare drives the growth of the retail segment in the market.
The e-commerce sector is the fastest growing in the animal health market owing to rising purchasing of animal health care products like pet medicines and supplements through online channels. E-commerce offers greater convenience, wider product choice, and attractive prices, which make it a preferred choice among consumers. Increasing usage of smartphones, better Internet connectivity, and growing popularity of online health services also contribute to fast growth. The growing prevalence of subscription services and direct deliveries also promote the rapid expansion of the e-commerce sector in animal health.
By End Use, veterinary hospitals and clinics segment dominated the animal health market in 2025, point-of-care testing segment is the fastest growing
Veterinary hospitals and clinics segment dominated the animal health market in 2025 as the demand for professional services related to veterinary medicine has been increasing. The segment is characterized by high-quality care that involves trained veterinarians and medical infrastructure. Increased pet ownership and demand for diseases management in livestock ensure the growth of patient numbers all around the world. The facilities will continue dominating in vaccination, diagnostics, and emergency care of animals and will stay the leading end-user in the global market for animal healthcare.
Point-of-care testing segment is the fastest-growing in the animal health market due to the increased need for quick and effective diagnosis at veterinary facilities. Point-of-care testing makes it possible to detect a disease quickly, take an appropriate decision and increase the chances for successful treatment of livestock and pets. Increased attention to preventive medicine and infectious diseases only contribute to the popularity of the segment. Advances in technology and increased interest in point-of-care diagnostics are the key driving forces behind its development.
Regional Analysis
|
Region |
Major Country |
Share within Region (%) |
|---|---|---|
|
North America |
United States |
93.1% |
|
Europe |
United Kingdom |
24.2% |
|
Asia Pacific |
Australia |
10.1% |
|
Middle East & Africa |
UAE |
13.8% |
|
Latin America |
Brazil |
55.6% |
North America Animal Health Market Insights
North America occupied the largest position in the animal health market in 2025, contributing more than 48.20% to the overall revenue share. It is because of the high prevalence of pet ownership, higher expenditure on veterinary services, and well-developed animal health care infrastructure in the region. High adoption of preventive healthcare products, vaccinations, diagnostic tests, and nutrition products is further aiding in the growth of the market. The presence of prominent animal health care players, well-developed vet hospitals, and growing adoption of pet health insurance further boost the market leadership in the region.

Get Customized Report as per Your Business Requirement - Enquiry Now
Asia Pacific Animal Health Market Insights
Asia-Pacific is anticipated to grow at the highest CAGR of about 12.18% in the animal health market in the forecast period. This is due to the increasing number of pet ownership, rising production of livestock, and awareness of animal health management and disease prevention. Moreover, an increase in disposable income, developments in the veterinary sector, and increased demand for high quality food items derived from animals are boosting the expansion of the market. Besides, the regulatory bodies in the region are paying attention towards livestock diseases and food safety.
Europe Animal Health Market Insights
The growth of the Europe animal health market is supported by the growing awareness about animal welfare, stringent laws related to food safety, and the rising adoption of preventive veterinary healthcare services. The rise in the number of pets and expenditure spent on the treatment of these companion animals is helping the market grow. Moreover, there have been significant developments in the form of investments made in livestock disease prevention techniques as well as precision farming. Apart from this, the growing awareness about zoonosis, improvement in veterinary healthcare facilities, and advancements in biotechnology and veterinary diagnostics are helping the market grow.
Middle East & Africa and Latin America Animal Health Market Insights
The Middle East & Africa and Latin America animal health markets are growing owing to increasing livestock production, adoption of pets, and better awareness levels about animal health. The focus of governments on disease prevention, food safety, and increased livestock productivity has contributed to increasing demand for veterinary pharmaceuticals, vaccines, and diagnostic tests. In the case of Middle East, growth in veterinary infrastructure development along with growing expenses on pet care is helping boost the market. In Africa, there has been an increase in demand for solutions for managing diseases in livestock.
Market Dynamics
Growth Drivers: Rising Pet Ownership and Increasing Spending on Veterinary Care Accelerating Demand for Advanced Animal Health Products Globally Worldwide
Increase in pet ownership and investment in veterinary health services are two major factors contributing to growth in the animal health market. There has been a noticeable trend towards treating pets like other family members, which has raised their need for preventive health services, diagnostic and vaccination services, and nutritional health products. Awareness about the wellbeing and proper care of animals is promoting more visits to the vet along with advanced treatment options. Moreover, the rise in disposable income along with changing lifestyle trends is also facilitating investments in premium products and services related to animal healthcare. Increased use of insurance services for pets along with specialization in veterinary health clinics has been further adding fuel to the growing demand.
Restraints: Stringent Regulatory Approvals and Concerns Regarding Antibiotic Resistance Impacting Development of Animal Health Products Across Global Markets Worldwide
Strict regulatory requirements and issues arising from antimicrobial resistance are posing numerous challenges for the animal health sector. Development and marketing of animal pharmaceuticals and vaccines involve rigorous clinical trials, stringent regulatory compliance procedures, and stringent approvals processes, which translate into higher costs in developing animal health products. There are also increased government regulations on the use of antibiotics for production animals to prevent issues relating to antimicrobial resistance. These regulations have resulted in fewer and limited options of the use of animal healthcare products. Adherence to different international safety and quality standards adds another challenge for companies operating in the animal health industry.
Opportunities: Expansion of Pet Insurance Coverage and Rising Adoption of Preventive Veterinary Care Creating Significant Animal Healthcare Market Growth Opportunities
The rise in insurance cover for pets along with increased uptake of preventive measures in animal health is creating immense growth prospects for the animal health industry. Rising consciousness among pet owners about the importance of health maintenance in the long run has resulted in an increased willingness to pay for health screenings, immunizations, diagnostic tests, and health maintenance programs. The advent of cheaper and more accessible insurance schemes is aiding in the provision of cutting-edge veterinary care, lowering costs borne by consumers. Furthermore, growing demand for preventive healthcare products including nutritional products, parasite control solutions, and health monitoring solutions is further boosting industry growth.
Recent Developments:
-
2025: Zoetis revealed a diversified R&D pipeline with 12 potential blockbuster animal health products in 2025. The company highlighted next-generation therapies, chronic pain management products, diagnostics, vaccines, and companion animal medicines designed to accelerate long-term growth and veterinary innovation globally
-
2025: Zoetis received conditional USDA approval for its H5N2 avian influenza vaccine for chickens in 2025. The vaccine was developed to help poultry producers manage highly pathogenic bird flu outbreaks affecting commercial poultry farms across the United States.
-
2025: IDEXX Laboratories expanded veterinary diagnostic capabilities in 2025 by launching enhanced AI-powered diagnostic technologies and cloud-connected veterinary workflow systems. The company strengthened companion-animal testing services and digital laboratory management solutions for veterinary clinics worldwide.
-
2024: Merck Animal Health completed the acquisition of Elanco’s aqua business in 2024. The deal added fish vaccines, anti-parasitic products, and water-quality management technologies, expanding Merck’s aquaculture healthcare portfolio and strengthening sustainable seafood production solutions globally.
-
2024: Zoetis updated Librela’s prescribing label in 2024 after reports of rare neurological side effects in dogs. The company instructed veterinarians to provide updated safety information and pet-owner guidance regarding osteoarthritis treatment risks.
Animal Health Market Key Players are:
-
Zoetis Inc.
-
MSD Animal Health (Merck Animal Health)
-
Boehringer Ingelheim
-
Elanco Animal Health
-
IDEXX Laboratories
-
Virbac
-
Ceva Santé Animale
-
Vetoquinol S.A.
-
Dechra Pharmaceuticals PLC
-
Neogen Corporation
-
Phibro Animal Health Corporation
-
Norbrook Laboratories
-
Ourofino Saúde Animal
-
Krka
-
Orion Corporation
-
AnimalCare AB
-
Hester Biosciences Limited
-
Bayer Animal Health
-
Novartis
-
Thermo Fisher Scientific
Animal Health Market Report Scope:
| Report Attributes | Details |
|---|---|
| Market Size in 2025 | USD 67.13 Billion |
| Market Size by 2035 | USD 187.03 Billion |
| CAGR | CAGR of 10.79% From 2026 to 2035 |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Historical Data | 2022-2024 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Animal Type (Production Animals, Companion Animals) • By Product (Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Equipment & Disposables, Others) • By Distribution Channel (Retail, E-Commerce, Hospital) • By End Use (Veterinary Reference Laboratories, Point-of-care Testing, Veterinary Hospitals & Clinics, Others) |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
| Company Profiles | Zoetis Inc., MSD Animal Health (Merck Animal Health), Boehringer Ingelheim, Elanco Animal Health, IDEXX Laboratories, Virbac, Ceva Santé Animale, Vetoquinol S.A., Dechra Pharmaceuticals PLC, Neogen Corporation, Phibro Animal Health Corporation, Norbrook Laboratories, Ourofino Saúde Animal, Krka, Orion Corporation, AnimalCare AB, Hester Biosciences Limited, Bayer Animal Health (Elanco), Novartis (Animal Health segment), Thermo Fisher Scientific, and Others. |